{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:01:58Z","timestamp":1778896918712,"version":"3.51.4"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177204","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T18:26:27Z","timestamp":1494527187000},"page":"e0177204","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry"],"prefix":"10.1371","volume":"12","author":[{"given":"Mariano","family":"Provencio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Sab\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Gomez-Codina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8791-7660","authenticated-orcid":true,"given":"Maria","family":"Torrente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Llanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Gum\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Quero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Garc\u00eda-Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Lavernia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natividad","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Saez-Cusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delvys","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Javier","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of GOTEL (Spanish Lymphoma Oncology Group)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"issue":"Supl 1","key":"ref1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0025-7753(08)76438-8","article-title":"An\u00e1lisis de la incidencia, la supervivencia y la mortalidad seg\u00fan las principales localizaciones tumorales, 1985\u20132019: linfomas no Hodgkin","volume":"131","author":"R Marcos-Gragera","year":"2008","journal-title":"Med Clin (Barc)"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"The Non-Hodgkin\u00b4s Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u00b4s lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin\u00b4s lymphomas: clinical features of the major histologic subtypes","volume":"16","author":"JO Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref4","first-page":"200","article-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"S.H. Swerdlow","year":"2008"},{"issue":"suppl 3","key":"ref5","doi-asserted-by":"crossref","first-page":"iii76","DOI":"10.1093\/annonc\/mdu200","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"M Dreyling","year":"2014","journal-title":"Ann of Oncol"},{"key":"ref6","article-title":"Cancer incidence in five continents","volume":"Vol. IX","author":"MP Curado","year":"2009"},{"issue":"27","key":"ref7","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project","volume":"27","author":"M Federico","year":"2009","journal-title":"J Clin Oncol"},{"issue":"22","key":"ref8","first-page":"2575","article-title":"Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial","volume":"34","author":"C Sarkozy","year":"2016"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y","article-title":"Histological transformation of non-Hodgkin\u00b4s Lymphomas. A prospective study","volume":"44","author":"MH Cullen","year":"1979","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO;2-M","article-title":"An autopsy study of histologic progression in non-Hodgkin\u00b4s lymphomas.192 cases from the National Cancer Institute","volume":"52","author":"AJ Garvin","year":"1983","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin&apos;s lymphomas","volume":"311","author":"SJ Horning","year":"1984","journal-title":"NEngl J Med"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.bjc.6601006","article-title":"Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?","volume":"89","author":"I Chau","year":"2003","journal-title":"British Journal of Cancer"},{"issue":"17","key":"ref13","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2009.26.1693","article-title":"Prognostic factors in follicular lymphoma","volume":"28","author":"T Relander","year":"2010","journal-title":"J ClinOncol"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/annonc\/mdp053","article-title":"Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting","volume":"20","author":"SA van de Schans","year":"2009","journal-title":"Ann Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","article-title":"Improved survival of follicular lymphoma patients in United States","volume":"23","author":"WT Swenson","year":"2005","journal-title":"J Clin Oncol"},{"issue":"33","key":"ref16","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1200\/JCO.2005.03.1674","article-title":"New treatment options have changed the survival of patients with follicular lymphoma","volume":"23","author":"RI Fisher","year":"2005","journal-title":"J ClinOncol"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12094-012-0813-3","article-title":"Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?","volume":"14","author":"M Provencio","year":"2012","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0959-8049(95)00635-4","article-title":"The follicular non-Hodgkin\u00b4s lymphomas II. Prognostic factors: what do they mean?","volume":"32A","author":"JW Denham","year":"1996","journal-title":"Eur J Cancer"},{"key":"ref19","first-page":"89","article-title":"Prognostic factors in follicular lymphomas","volume":"20","author":"B Coiffer","year":"1993","journal-title":"Semin Oncol"},{"issue":"Supl.2","key":"ref20","first-page":"11","article-title":"The treatment of indolent lymphomas: Watchful waiting versus aggressive combined modality treatment","volume":"25","author":"RC Young","year":"1988","journal-title":"Semin Hematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/0277-5379(91)90425-D","article-title":"Low-grade follicular lymphomas: Analysis of prognosis in a series of 281 patients","volume":"27","author":"P Soubeyran","year":"1991","journal-title":"Eur J Cancer"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/annonc\/mdv376","article-title":"Life expectancy of young adults with follicular lymphoma","volume":"26","author":"A Conconi","year":"2015","journal-title":"Ann Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1200\/JCO.2010.33.4474","article-title":"Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database","volume":"30","author":"P Solal-C\u00e9ligny","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/cncr.28659","article-title":"The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States","volume":"120","author":"LJ Nastoupil","year":"2014","journal-title":"Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1200\/JCO.2012.45.0866","article-title":"R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-state follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi","volume":"31","author":"M Federico","year":"2013","journal-title":"J ClinOncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1200\/JCO.2007.15.5358","article-title":"Impact of rituximab and or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphomas: a GELA study","volume":"26","author":"C Sebban","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bjh.13451","article-title":"Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults","volume":"170","author":"SA Gangatharan","year":"2015","journal-title":"Br J Haematol"},{"issue":"22","key":"ref28","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","article-title":"Improved survival of follicular lymphoma patients in the United States","volume":"23","author":"WT Swenson","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ajh.23708","article-title":"The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatments","volume":"89","author":"C Nabhan","year":"2014","journal-title":"Am J Hematol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3109\/10428191003743460","article-title":"Patterns of survival of follicular lymphomas at a single institution through three decades","volume":"51","author":"A Conconi","year":"2010","journal-title":"Leukemia and Lymphoma"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T09:41:21Z","timestamp":1602063681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177204"}},"subtitle":[],"editor":[{"given":"Jose Angel","family":"Martinez Climent","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177204","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}